Vascularization plays a pivotal role, as inadequate blood supply can severely hinder healing. CD47, a protein present on nearly all human cells, has been linked to tissue regeneration and blood ...

Gilead is dealing with more turbulence in its development of CD47-targeting antibody magrolimab, with a partial clinical hold placed on the drug by the FDA in acute myeloid leukaemia (AML).